Noul Co., Ltd. unveiled the results of a clinical study conducted by miLab in two African countries. Noul participated in the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting 2023 held from October 18th to 22nd, in Chicago, USA. In a lightning talk and at the poster session held on October 20th, Dr. Cristian Koepfli from University of Notre Dame, USA, presented the key results of a clinical performance study on Noul's miLab in collaboration with scientists from Gondar University, Ethiopia, Kwame Nkrumah University of Science and Technology, Ghana, and Noul.

In the study unveiled by the poster titled "A digital microscope for the diagnosis of Plasmodium falciparum and Plasmodium vivax parasites, including P. falciparum with hrp2/hrp3 deletion", a total of 1,649 patients enrolled in Gondar, Ethiopia, and Kumasi, Ghana were tested. In the study, the scientists compared the sensitivity and specificity of the qPCR with those of miLab, field microscopy, and Rapid Diagnostic Test (RDT) respectively. Diagnosis of P. f. falciparum infections included cases withhrp2/hrp3 gene deletion with rendersites 'invisible' to common rapid diagnostic tests.

The ability and reliability of the miLab to show the parasite on a screen is a major benefit over other diagnostic methods. This new study in Ethiopia and Ghana confirmed the clinical performance of miLab as a reliable new tool in the diagnosis of P. falciparUM and P. vivax malaria. The company expects the potential to address the global challenge of malaria diagnosis, including the high applicability of miLab in diagnosing zones with the deletion of thehrp2/3 genes.

The results of the study presented at the poster session by Dr.Cristian Koepfli will be published in an international scientific journal.